Clinical efficacy of photoselective vaporization of prostate (Green Light PV) for benign prostatic hyperplasia with heart failure: a short-term prospective randomized trial

AIM: To evaluate the clinical efficacy of photoselective vaporization of the prostate (PVP) for the treatment of patient with benign prostatic hyperplasia (BPH) with heart failure. METHODS: A total of 60 BPH patients with heart failure were randomly allocated to PVP (n=30) or transurethral resection of the prostate (TURP, n=30). Perioperative parameters, functional outcome, and adverse events up to 1 month postoperatively were compared between groups. RESULTS: Although satisfactory effects were observed in both groups, patients who underwent PVP experienced less bleeding complications, less bladder irrigation solution, shorter time of catheterization, and shorter hospital stay. CONCLUSION: PVP is a safe and effective surgical approach for BPH patients with heart failure.